The Differential Ability of IL-8 and Neutrophil-Activating Peptide-2 to Induce Attenuation of Chemotaxis Is Mediated by Their Divergent Capabilities to Phosphorylate CXCR2 (IL-8 Receptor B)

Journal of Immunology

Volumn 158, Issue 12, 1997, Pages 5927-5933

  Ben Baruch, Adit ^a,c   Grimm, Michael ^a   Bengali, Kathleen ^a   Evans, Gerald A ^a   Chertov, Oleg ^a   Wang, Ji Ming ^a   Howard, O M Zack ^a   Mukaida, Naofumi ^b   Matsushima, Kouji ^b   Oppenheim, Joost J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KANAZAWA UNIVERSITY   (Japan)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BETA THROMBOGLOBULIN; CONNECTIVE TISSUE ACTIVATING PEPTIDE; CONNECTIVE TISSUE-ACTIVATING PEPTIDE; INTERLEUKIN 8; INTERLEUKIN RECEPTOR; PEPTIDE; PPBP PROTEIN, HUMAN;

ARTICLE; CELL CULTURE; CONNECTIVE TISSUE; GENETIC TRANSFECTION; HUMAN; METABOLISM; NEUTROPHIL CHEMOTAXIS; PHOSPHORYLATION; PHYSIOLOGY; SERODIAGNOSIS;

BETA-THROMBOGLOBULIN; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; CONNECTIVE TISSUE; HUMANS; INTERLEUKIN-8; PEPTIDES; PHOSPHORYLATION; PRECIPITIN TESTS; RECEPTORS, INTERLEUKIN; TRANSFECTION;

EID: 0031570454     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Zwahlen, R., A. Walz, and A. Rot. 1993. In vitro and in vivo activity and pathophysiology of human interleukin-8 and related peptides. Int. Rev. Exp. Pathol. 34B:27.
2. 2-terminally processed forms. Eur. J. Immunol. 20:2113.
3. L'Heureux, G. P., S. Bourgoin, N. Jean, S. R. McColl, and P. H. Naccache. 1995. Diverging signal transduction pathways activated by interleukin-8 and related chemokines in human neutrophils: interleukin-8, but not NAP-2 or GROα, stimulates phospholipase D activity. Blood 85:522.
4. Walz, A., R. Burgener, B. Car, M. Baggiolini, S. L. Kunkel, and R. M. Strieter. 1991. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8. J. Exp. Med. 174:1355.
5. Leonard, E. J., T. Yoshimura, A. Rot, K. Noer, A. Walz, M. Baggiolini, D. A. Walz, E. J. Goetzl, and C. W. Castor. 1991. Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor. J. Leukocyte Biol. 49:258.
6. Clark-Lewis, I., B. Moser, A. Walz, M. Baggiolini, G. J. Scott, and R. Aebersold. 1991. Chemical synthesis, purification, and characterization of two inflammatory proteins, neutrophil activating peptide 1 (interleukin-8) and neutrophil activating peptide 2. Biochemistry 30:3128.
7. Kudowska, A., A. B. Cohen, K. K. Carr, M. D. Stevens, E. J. Miller, G. Mullenbach, and P. Tekamp-Olson. 1994. Biological and kinetic characterization of recombinant human macrophage inflammatory peptides 2 alpha and beta and comparison with the neutrophil activating peptide 2 and interleukin 8. Cytokine 6:124.
8. Loetscher, P., M. Seitz, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1994. Both interleukin-8 receptors independently mediate chemotaxis: Jurkat cells transfected with IL-8R1 or IL-8R2 migrate in response to IL-8, GROα and NAP-2. FEBS Lett. 341:187.
9. Ahuja, S. K., J. C. Lee, and P. M. Murphy. 1996. CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B: determinants of high affinity binding and receptor activation are distinct. J. Biol. Chem. 271:225.
10. Cerretti, D. P., C. J. Kozlosky, T. Vanden Bos, N. Nelson, D. P. Gearing, and M. P. Beckman. 1993. Molecular characterization of receptors for human interleukin-8. GRO/melanoma growth-stimulatory activity and neutrophil activating peptide-2. Mol. Immunol. 30:359.
11. Schnitzel, W., U. Monschein, and J. Besemer. 1994. Monomer-dimer equilibria of interleukin-8 and neutrophil-activating peptide 2: evidence for IL-8 binding as a dimer and oligomer to IL-8 receptor B. J. Leukocyte Biol. 55:763.
12. Krieger, M., T. Brunner, S. C. Bischoll, V. von Tscharner, A. Walz, B. Moser, M. Baggiolini, and C. A. Dahinden. 1992. Activation of human basophils through the IL-8 receptor. J. Immunol. 149:2662.
13. Schnitzel, W., B. Garbeis, U. Monschein, and J. Besemer. 1991. Neutrophil activating peptide-2 binds with two affinities to receptor(s) on human neutrophils. Biochem. Biophys. Res. Commun. 180:301.
14. Petersen, F., H.-D. Flad, and E. J. Brandt, 1994. Neutrophil-activating peptides NAP-2 and IL-8 bind to the same sites on neutrophils but interact in different ways: discrepancies in binding affinities, receptor densities, and biologic effects. J. Immunol. 152:2467.
15. Ben-Baruch, A., K. Bengali, K. Tani, L. Xu, J. J. Oppenheim, and J. M. Wang. 1997. IL8 and NAP-2 differ in their capacities to bind and chemoattract 293 cells transfected with either IL8 receptor type A or type B. Cytokine 9:37.
16. Holmes, W. E., J. Lee, W.-J. Kuang, G. C. Rice, and W. I. Wood. 1991. Structure and functional expression of a human interleukin-8 receptor. Science 253:1278.
17. Murphy, P. M., and H. L. Tiffany. 1991. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 253:1280.
18. Ben-Baruch, A., D. F. Michiel, and J. J. Oppenheim. 1995. Signals and receptors involved in recruitment of inflammatory cells. J. Biol. Chem. 270:11703.
19. Lefkowitz, R. J., W. P. Hausdorff, and M. G. Caron. 1990. Role of phosphorylation in desensitization of the β-adrenoccptor. Trends Pharmacol. Sci. 11:190.
20. Lohse, M. J. 1993. Molecular mechanisms of membrane receptor desensitization. Biochim. Biophys. Acta 1179:171.
21. Inglese, J., N. J. Freedman, W. J. Koch, and R. J. Lefkowitz. 1993. Structure and mechanism of the G protein-coupled receptor kinases. J. Biol. Chem. 268:23735.
22. Premont, R. T., J. Inglese, and R. J. Lefkowitz. 1995. Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J. 9:175.
23. Dohlman, H. G., J. Thorner, M. G. Caron, and R. J. Lefkowitz. 1991. Model systems for the study of seven-trans membrane-segment receptors. Annu. Rev. Biochem. 60:653.
24. Ali, H., R. M. Richardson, E. D. Tomhave, J. R. Didsbury, and R. Snyderman. 1993. Differences in phosphorylation of formylpeptide and C5a chemoattractant receptors correlate with differences in desensitizafion. J. Biol. Chem. 268:24247.
25. Richardson, R. M., R. A. DuBose, H. Ali, E. D. Tomhave, B. Haribabu, and R. Snyderman. 1995. Regulation of human interleukin-8 receptor A: identification of a phosphorylation site involved in modulating receptor functions. Biochemistry 34:14193.
26. Ben-Baruch, A., K. M. Bengali, A. Biragyn, J. J. Johnston, J.-M. Wang, J. Kim, A. Chuntharapai, D. F. Michiel, J. J. Oppenheim, and D. J. Kelvin. 1995. Interleukin-8 receptor β: the role of the carboxyl terminus in signal transduction. J. Biol. Chem. 270:9121.
27. Mueller, S. G., W. P. Schraw, and A. Richmond. 1995. Activation of protein kinase C enhances the phosphorylation of the type B interleukin-8 receptor and stimulates its degradation in non-hematopoietic cells. J. Biol. Chem. 270:10439.
28. Mueller, S. G., W. P. Schraw, and A. Richmond. 1994. Melanoma growth stimulatory activity enhances the phosphorylation of the class II interleukin-8 receptor in non-hematopoielic cells. J. Biol. Chem. 269:1973.
29. Morohashi, H., T. Miyawaki, H. Nomura, K. Kuno, S. Mirakami, K. Matsushima, and N. Mukaida. 1995. Expression of both types of human inlerleukin-8 receptors on mature neutrophils, monocytes, and natural killer cells. J. Leukocyte Biol. 57:180.
30. Grob, P. M., E. David, T. C. Warren, R. P. DeLeon, P. R. Farina, and C. A. Homon. 1990. Characterization of a receptor for human monocyte-derived neutrophil chemotactic factor/interleukin-8. J. Biol. Chem. 265:8311.
31. Hamanaka, R., M. R. Smith, P. M. O'Connor, S. Maloid, K. Mihalic, J. L. Spivak, D. L. Longo, and D. K. Ferris. 1995. Polo-like kinase is a cell cycle-regulated kinase activated during mitosis. J. Biol. Chem. 270:21086.
32. Erwin, R. A., R. A. Kirken, M. G. Malabarba, W. L. Farrar, and H. Rui. 1995. Prolactin activates ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless. Endocrinology 136:3512.
33. Rozakis-Adcock, M., R. Fernley, T. Pawson, and D. Bowtell. 1993. The SH2 and SH3 domains of mammalian GRB2 eouple the EGF receptor to the RAS activator mSOS1. Nature 363:83.
34. Prossnitz, E. R., C. M. Kim, J. L. Benovic, and R. D. Ye. 1995. Phosphorylation of the N-formyl peptide receptor carboxyl terminus by the G protein-coupled receptor kinase. GRK2. J. Biol. Chem. 270:1130.
35. Giannini, E., and F. J. Boulay. 1995. Phosphorylation, dephosphorylation, and recycling of the C5a receptor in differentiated HL60 cells. J. Immunol. 154:4055.
36. Takano, T., Z-I. Honda, C. Sakanaka, T. Izumi, K. Kameyama, K. Haga, T. Haga, K. Kurokawa, and T. Shimizu. 1994. Role of cytoplasmic tail phosphorylation sites of platelet-activating factor receptor in agonist-induced desensitization. J. Biol. Chem. 269:22453.
37. Krupnick, J. G., V. V. Gurevich, T. Schepers, H. E. Hamm, and J. L. Benovic. 1994. Arrestin-rhodopsin interaction: multi-site binding delineated by peptide inhibition. J. Biol. Chem. 269:3226.
38. Gurevich, V. V., and J. L. Benovic. 1993. Visual arrestin interaction with rhodopsin: sequential multisite binding ensures strict selectivity toward light-activated phosphorylated rhodopsin. J. Biol. Chem. 268:11628.
39. 2-adrenergic receptor desensitization: delineation with specific inhibitors. J. Biol. Chem. 265:3202.
40. Benovic, J. L., C. Staniszewski, F. Mayor, Jr., M. G. Caron, and R. J. Lefkowitz. 1988. β-adrenergic receptor kinase: activity of partial agonist for stimulation of adenylate cyclase correlates with ability to promote receptor phosphorylation. J. Biol. Chem. 263:3893.
41. Malkowski, M. G., J. Y. Wu, J. B. Lazar, P. H. Johnson, and B. F. P. Edwards. 1995. The crystal structure of recombinant human neutrophil-activating peptide-2 (M6L) at 1.9-A resolution. J. Biol. Chem. 270:7077.